Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Clinical Trials in CNS

18th November to 19th November 2013, London, United Kingdom

Overview

Open/Close

Special Managers Rate £799, limited availability. Book online today

SMi is delighted to announce that its highly anticipated and respected 12th annual Clinical Trials in CNS Conference is coming to London. With an ever increasing average life expectancy, neurodegenerative diseases are increasingly becoming more prevalent in society. With this comes a need for new and improved therapies for treating these neurodegenerative conditions. From Alzheimer's to Parkinson's disease, the target and mechanism by which a disease manifests itself presents unique challenges in how to approach such treatments not to mention ethical and legal issues behind treatment and trial design.

Join SMi as we look at new approaches taken in this field towards a number of neurodegenerative disorders. From clinical trial modelling and simulation to the role of biomarkers, SMi takes a detailed look into many aspects of drug discovery and delivery of CNS therapeutics.This exciting  conference will give delegates an opportunity to gain insights through case studies and interactive discussion into best practices in clinical trials. 

Benefits of Attending

Open/Close

Featured Speakers

Open/Close

Who Should Attend

Open/Close
World Courier